AMERIPRISE FINANCIAL INC
For the period ended Mar 31, 2024. Filed May 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 6, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Shareholders’ Equity
- Shareholders’ Equity
The following table presents the amounts related to each component of OCI:
| Three Months Ended March 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 | 2023 | |||||
| Pretax | Income Tax Benefit (Expense) | Net of Tax | Pretax | Income Tax Benefit (Expense) | Net of Tax | |
| (in millions) | ||||||
| Net unrealized gains (losses) on securities: | ||||||
| Net unrealized gains (losses) on securities arising during the period (1) | $(236) | $52 | $(184) | $566 | $(124) | $442 |
| Reclassification of net (gains) losses on securities included in net income (2) | — | — | — | (3) | 1 | (2) |
| Impact of benefit reserves and reinsurance recoverables | 8 | (2) | 6 | (12) | 2 | (10) |
| Net unrealized gains (losses) on securities | (228) | 50 | (178) | 551 | (121) | 430 |
| Net unrealized gains (losses) on derivatives: | ||||||
| Net unrealized gains (losses) on derivatives arising during the period | — | — | — | 3 | (1) | 2 |
| Net unrealized gains (losses) on derivatives | — | — | — | 3 | (1) | 2 |
| Effect of changes in discount rate assumptions on certain long-duration contracts | 88 | (19) | 69 | (83) | 18 | (65) |
| Effect of changes in instrument-specific credit risk on MRBs | (48) | 11 | (37) | 204 | (43) | 161 |
| Foreign currency translation | (18) | — | (18) | 42 | (9) | 33 |
| Total other comprehensive income (loss) | $(206) | $42 | $(164) | $717 | $(156) | $561 |
(1) Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period.
(2) Reclassification amounts are recorded in Net investment income.
Other comprehensive income (loss) related to net unrealized gains (losses) on securities includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.
Index
The following table presents the changes in the balances of each component of AOCI, net of tax:
| Net Unrealized Gains (Losses) on Securities | Net Unrealized Gains (Losses) on Derivatives | Effect of Changes in Discount Rate Assumptions on Certain Long-Duration Contracts | Effect of Changes in Instrument-Specific Credit Risk on MRBs | Defined Benefit Plans | Foreign Currency Translation | Other | Total | |
|---|---|---|---|---|---|---|---|---|
| (in millions) | ||||||||
| Balance at January 1, 2024 | $(1,241) | $5 | $(126) | $(85) | $(60) | $(258) | $(1) | $(1,766) |
| OCI before reclassifications | (178) | — | 69 | (37) | — | (18) | — | (164) |
| Total OCI | (178) | — | 69 | (37) | — | (18) | — | (164) |
| Balance at March 31, 2024 | $(1,419) | $5 | $(57) | $(122) | $(60) | $(276) | $(1) | $(1,930) |
| Balance at January 1, 2023 | $(2,043) | $3 | $(72) | $(20) | $(75) | $(338) | $(1) | $(2,546) |
| OCI before reclassifications | 432 | 2 | (65) | 161 | — | 33 | — | 563 |
| Amounts reclassified from AOCI | (2) | — | — | — | — | — | — | (2) |
| Total OCI | 430 | 2 | (65) | 161 | — | 33 | — | 561 |
| Balance at March 31, 2023 | $(1,613) | $5 | $(137) | $141 | $(75) | $(305) | $(1) | $(1,985) |
For the three months ended March 31, 2024 and 2023, the Company repurchased a total of 1.2 million shares and 1.6 million shares, respectively, of its common stock for an aggregate cost of $507 million and $506 million, respectively. On July 24, 2023, the Company’s Board of Directors authorized an additional $3.5 billion for the repurchase of the Company’s common stock through September 30, 2025. As of March 31, 2024, the Company had $2.6 billion remaining under this share repurchase authorization.
The Company may also reacquire shares of its common stock under its share-based compensation plans related to restricted stock awards and certain option exercises. The holders of restricted shares may elect to surrender a portion of their shares on the vesting date to cover their income tax obligation. These vested restricted shares are reacquired by the Company and the Company’s payment of the holders’ income tax obligations are recorded as a treasury share purchase.
For the three months ended March 31, 2024 and 2023, the Company reacquired 0.3 million shares and 0.3 million shares, respectively, of its common stock through the surrender of shares upon vesting and paid in the aggregate $99 million and $87 million, respectively, related to the holders’ income tax obligations on the vesting date. Option holders may elect to net settle their vested awards resulting in the surrender of the number of shares required to cover the strike price and tax obligation of the options exercised. These shares are reacquired by the Company and recorded as treasury shares. For the three months ended March 31, 2024 and 2023, the Company reacquired 0.2 million shares and 0.2 million shares, respectively, of its common stock through the net settlement of options for an aggregate value of $99 million and $63 million, respectively.
During the three months ended March 31, 2024 and 2023, the Company reissued 0.7 million and 0.6 million, respectively, treasury shares for restricted stock award grants, performance share units and issuance of shares vested under advisor deferred compensation plans.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.